Healthcare Bizdev
HCBD-Pro Services Client Subscribers

HCBD-PRO Services

Query News -

Welcome <Guest> Login
Amgen, Inc.
 
One Amgen Center Dr
Thousand Oaks , CA   91320-1799   USA
805-447-1000
 
Company Website:
http://www.amgen.com/
Newsroom
Contact the Company

 
Business Focus:
Biotechnology
Company Description:
Amgen discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.
 


Company Officials:
Jean J. Lim
[President]
 
John Meyers
[Executive Director, Inflammation Marketing - Strategy, Planning & Operations]
 
Dianne Kane Parker PharmD
[Health Outcomes and Pharmacoeconomics Regional Medical Liaison, Medical Affairs]
 
Stewart Turner
[Director of Medical Communications]
 
Gary M. Gelb RPh
[Executive Director - Strategic Planning]
 
Dan Sullivan
[Associate Director of Marketing]
 
Mary Hall Gregg PhD
[VP Information Systems Application Services]
 
Michael Hatten
[US Commercial Technology Lead]
 
Sari Ratican
[Chief Privacy Officer - Worldwide Compliance & Business Ethics]
 
Susan Capps
[Executive Director, Pricing & Reimbursement]
 
Julie Grim
[Senior Account Executive]
 
Robert Jahr
[Executive Business Director]
 
Ray Jordan
[Senior Vice President of Corporate Affairs]
 
Jen Norton
[VP - Head of US Value & Access]
 
Mike Sigler
[Executive Director Corporate Acct and Payor Reimbursement]
 
View Additional Employees and Representatives
View Past Employees/Others with Past Affiliations

Company News/Coverage:
Amgen And Harvard Pilgrim Agree To First Cardiovascular Outcomes-Based Refund Contract For Repatha (Evolocumab)
Amgen Enters Into Agreement With Inovalon and Avalere to Engage Value-Based Contracting Opportunities
CURE Magazine Announces Winner of the 2011 Extraordinary Healer Award for Oncology Nursing
US Oncology: 2011 Extraordinary Healer Award for Oncology Nursing Finalists Announced
Amgen: Breakaway From Cancer Launches Newly-Enhanced Website Offering Comprehensive, Tailored Support for Cancer Patients
View all remaining Company News/Coverage headlines
About Us | Purchase Pro | Contact Us

© 2006-2010 Healthcare BizDev, Inc. All rights reserved. Privacy Policy | Legal Conditions